» Articles » PMID: 19181846

E2A Proteins Maintain the Hematopoietic Stem Cell Pool and Promote the Maturation of Myelolymphoid and Myeloerythroid Progenitors

Overview
Specialty Science
Date 2009 Feb 3
PMID 19181846
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoiesis is a tightly controlled process maintained by a small pool of hematopoietic stem cells (HSCs). Here, we demonstrate that the LT-HSC, MPP, premegakaryocytic/erythroid, Pre CFU-E, Pre GM, MkP, and granulocyte-macrophage compartments were all significantly reduced in E2A-deficient bone marrow. Despite a severe depletion of erythroid progenitors, the erythrocyte and megakaryocyte compartments were equivalent in E2A-deficient bone marrow as compared with wild-type mice. E2A-deficient HSCs also failed to efficiently maintain the HSC pool on serial transplantation, and we demonstrate that the E2A proteins regulate cell cycle progression of HSCs by regulating the expression of p21(Cip1), p27(Kip1), and the thrombopoietin receptor, known regulators of HSC self-renewal activity. Based on these observations, we propose that the E2A proteins promote the developmental progression of the entire spectrum of early hematopoietic progenitors and to suppress an erythroid specific program of gene expression in alternative cell lineages. Last, the data mechanistically link E2A, cell cycle regulators, and the maintenance of the HSC pool in a common pathway.

Citing Articles

Early B-Cell Factor 1: An Archetype for a Lineage-Restricted Transcription Factor Linking Development to Disease.

Sigvardsson M Adv Exp Med Biol. 2024; 1459:143-156.

PMID: 39017843 DOI: 10.1007/978-3-031-62731-6_7.


The Function of E2A in B-Cell Development.

Miyazaki M, Miyazaki K Adv Exp Med Biol. 2024; 1459:97-113.

PMID: 39017841 DOI: 10.1007/978-3-031-62731-6_5.


promotes silica-induced epithelial-mesenchymal transition by modulating the miR-497-5p/TCF3 axis.

Zhou S, Li Y, Sun W, Ma D, Liu Y, Cheng D J Biomed Res. 2024; 38(2):163-174.

PMID: 38529638 PMC: 11001589. DOI: 10.7555/JBR.37.20220249.


Targeting TNF/IL-17/MAPK pathway in h leukemia: effects of OUL35, KJ-Pyr-9, and CID44216842.

Luo H, Li Q, Hong J, Huang Z, Deng W, Wei K Haematologica. 2024; 109(7):2092-2110.

PMID: 38385270 PMC: 11215385. DOI: 10.3324/haematol.2023.283647.


The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia.

Yang M, Tang Y, Zhu P, Lu H, Wan X, Guo Q Ann Hematol. 2023; 103(9):3385-3398.

PMID: 38148344 DOI: 10.1007/s00277-023-05595-7.


References
1.
Scott E, Simon M, Anastasi J, Singh H . Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994; 265(5178):1573-7. DOI: 10.1126/science.8079170. View

2.
Borghesi L, Aites J, Nelson S, Lefterov P, James P, Gerstein R . E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J Exp Med. 2005; 202(12):1669-77. PMC: 2212960. DOI: 10.1084/jem.20051190. View

3.
Iwasaki H, Mizuno S, Wells R, Cantor A, Watanabe S, Akashi K . GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity. 2003; 19(3):451-62. DOI: 10.1016/s1074-7613(03)00242-5. View

4.
Busslinger M . Transcriptional control of early B cell development. Annu Rev Immunol. 2004; 22:55-79. DOI: 10.1146/annurev.immunol.22.012703.104807. View

5.
Prabhu S, Ignatova A, Park S, Sun X . Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol Cell Biol. 1997; 17(10):5888-96. PMC: 232436. DOI: 10.1128/MCB.17.10.5888. View